[Table/Fig-5]:
Clinical features and signs of the patients. The data was statistically analysed using Chi-square test and the p-value of less than 0.05 was considered significant.
| CLINICAL FEATURES and SIGNS | WEIL FELIX POSITIVE | wEIL FELIX NEGATIvE | p-value | IgM ab + (both from Elisa and ifa) | IgM Ab - (both from ELISA and I FA) | p-value | |
|---|---|---|---|---|---|---|---|
| FEVER GRADE | HIGH | 129 (61.1%) | 82 (38.9%) | 0.0916 | 68 (31.5%) | 148(68.5%) | 0.0724 |
| MODERATE | 47 (52.2%) | 43 (47.8%) | 29 (22.1%) | 102(77.9%) | |||
| MILD | 24 (46.2%) | 28 (53.8%) | 18 (21.2%) | 67 (78.8%) | |||
| FEVER DURATION | Fever <7days | 33 (31.4%) | 72 (68.6%) | 0.0011 | 26 (26.5%) | 72 (73.5%) | 0.8756 |
| Fever 7-13 days | 76 (57.6%) | 56 (42.4%) | 44 (30.8%) | 99 (69.2%) | |||
| Fever 14-29 days | 40 (46.5%) | 46 (53.5%) | 24 (27.9%) | 62 (72.1%) | |||
| Fever > 30 days | 51 (46.8%) | 58 (53.2%) | 21 (20.0%) | 84 (80.0%) | |||
| RASH | PRESENT | 102 (61.4%) | 64 (38.6%) | <0.0001 | 86 (53.7%) | 74 (46.2%) | <0.0001 |
| ABSENT | 98 (36.8%) | 168 (63.2%) | 29 (10.6%) | 243(89.3%) | |||
| HEADACHE | PRESENT | 109 (46.8%) | 124 (53.2%) | 0.8269 | 63 (28.0%) | 162(72.0%) | 0.4988 |
| ABSENT | 91 (45.7%) | 108 (54.3%) | 52 (25.1%) | 155(74.9%) | |||
| NAUSEA/VOMITING | PRESENT | 128 (51.8%) | 119 (48.2%) | 0.0078 | 74 (45.8%) | 98 (54.2%) | <0.0001 |
| ABSENT | 72 (38.9%) | 113 (61.1%) | 41 (19.9%) | 219(80.1%) | |||
| MYALGIAS | PRESENT | 108 (50.7%) | 105 (49.3%) | 0.0700 | 78 (32.5%) | 162(67.5%) | 0.0020 |
| ABSENT | 92 (42.0%) | 127 (58.0%) | 37 (19.3%) | 155(80.7%) | |||
| ABDOMINAL PAIN | PRESENT | 97 (44.9%) | 119 (55.1%) | 0.5626 | 59 (25.1%) | 176(74.9%) | 0.4368 |
| ABSENT | 103 (47.7%) | 113 (52.3%) | 56 (28.4%) | 141(71.6%) | |||
| BLEEDING | PRESENT | 64 (47.4%) | 71 (52.6%) | 0.7548 | 18 (27.7%) | 47 (72.3%) | 0.8320 |
| ABSENT | 136 (45.8%) | 161 (54.2%) | 97 (26.4%) | 270(73.6%) | |||
| ANASARCA | PRESENT | 86 (44.1%) | 109 (55.9%) | 0.4068 | 54 (22.5%) | 186(77.5%) | 0.0303 |
| ABSENT | 114 (48.1%) | 123 (51.9%) | 61(31.8%) | 131(68.2%) | |||
| CNS SYMPTOM | PRESENT | 79 (48.5%) | 84 (51.5%) | 0.4814 | 42 (30.4%) | 96 (69.6%) | 0.2191 |
| ABSENT | 121 (45.0%) | 148 (55.0%) | 73 (24.8%) | 221(75.2%) | |||
| PALLOR | PRESENT | 91 (46.4%) | 105 (53.6%) | 0.9599 | 45 (32.8%) | 92 (67.2%) | 0.0460 |
| ABSENT | 109 (46.2%) | 127 (53.8%) | 70 (23.7%) | 225(76.3%) | |||
| CYANOSIS | PRESENT | 98 (47.3%) | 109 (52.7%) | 0.6756 | 64 (39.5%) | 98 (60.5%) | <0.0001 |
| ABSENT | 102 (45.3%) | 123 (54.7%) | 51 (18.9%) | 219 (81.1%) | |||
| OEDEMA | PRESENT | 115 (50.7%) | 112 (49.3%) | 0.0556 | 61 (25.5%) | 178(74.5%) | 0.5658 |
| ABSENT | 85 (41.5) | 120 (58.5%) | 54 (28.0%) | 139(72.0%) | |||
| ICTERUS | PRESENT | 89 (46.4%) | 103 (53.6%) | 0.9828 | 65 (22.6%) | 223(74.4%) | 0.0071 |
| ABSENT | 111 (46.3%) | 129 (53.8%) | 50 (34.7%) | 94 (65.3%) | |||
| ESCHAR | PRESENT | 12 (26.1%) | 34 (73.9%) | 0.0036 | 4 (21.1%) | 15 (78.9%) | 0.0002 |
| ABSENT | 188 (48.7%) | 198 (51.3%) | 111 (26.9%) | 302 (73.1%) | |||
| THROMBOCYT OPENIA | PRESENT | 92 (60.9%) | 59 (39.1%) | <0.0001 | 88 (36.8%) | 151(63.2%) | <0.0001 |
| ABSENT | 108 (38.4%) | 173 (61.6%) | 27 (14.0%) | 166 (86.0%) | |||
| LYMPHADEN OPATHY | PRESENT | 118 (53.6%) | 102 (46.4%) | 0.0018 | 91 (46.9%) | 103 (53.1%) | <0.0001 |
| ABSENT | 82 (38.7%) | 130 (61.3%) | 24 (10.1%) | 214 (89.9%) | |||
| HEPATOMEGALY | PRESENT | 128 (56.6%) | 98 (43.4%) | <0.0001 | 96 (45.5%) | 157(54.5%) | <0.0001 |
| ABSENT | 72 (34.9%) | 134 (65.1%) | 19 (11.4%) | 160(88.6%) | |||
| SPLENOMEGALY | PRESENT | 81 (39.1%) | 126 (60.9%) | 0.0042 | 49 (25.1%) | 146 (74.9%) | 0.5244 |
| ABSENT | 119 (52.9%) | 106 (47.1%) | 66 (27.8%) | 171(72.2%) | |||